Evidence map›Paper›PMID 36128409›Full record

ArticleOpen forum infectious diseases2022

Standardization of Epidemiological Surveillance of Group A Streptococcal Impetigo

Kate M Miller, Jonathan R Carapetis, Thomas Cherian, Roderick Hay, Michael Marks, Janessa Pickering, Jeffrey W Cannon, Theresa Lamagni, Lucia Romani, Hannah C Moore and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Kate M MillerWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0002-1142-7697
Jonathan R CarapetisWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0002-1182-9792
Thomas CherianMMGH Consulting, Geneva, Switzerland.
Roderick HaySt John's Institute of Dermatology, King's College London, United Kingdom.ORCID https://orcid.org/0000-0002-5835-1167
Michael MarksClinical Research Department, Faculty of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0002-7585-4743
Janessa PickeringWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0002-6441-2456
Jeffrey W CannonWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0002-1321-9605
Theresa LamagniUnited Kingdom Health Security Agency, London, United Kingdom.ORCID https://orcid.org/0000-0002-3965-8323
Lucia RomaniThe Kirby Institute, University of New South Wales Sydney, Sydney, Australia.ORCID https://orcid.org/0000-0001-9038-5300
Hannah C MooreWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0001-6434-8290
Chris A Van BenedenCDC Foundation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-6250-9238
Dylan D BarthWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0001-5687-7942
Asha C BowenWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.ORCID https://orcid.org/0000-0002-3242-1155
Strep A Vaccine Global Consortium (SAVAC) Burden of Disease Working Group
The Kids Research Institute Australia · AUCenters for Disease Control and Prevention · USLondon School of Hygiene & Tropical Medicine · GBKing's College London · GBUNSW Sydney · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

Impetigo is a highly contagious bacterial infection of the superficial layer of skin. Impetigo is caused by group A

Indexed as

epidemiologyimpetigoinfectious diseaseStreptococcus pyogenessurveillance

Identifiers

PMID36128409
PMCPMC9474945
OpenAlexW4296129464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.